One of the most interesting topics in science today is the relationship between the mind and the brain. Its study is being propelled particularly by the use of nuclear medicine imaging, and this theme was echoed throughout the 2007 SNM meeting.
One of the most interesting topics in science today is the relationship between the mind and the brain. Its study is being propelled particularly by the use of nuclear medicine imaging, and this theme was echoed throughout the 2007 SNM meeting.
Establishing a clinical context for such studies is not easy, and they may leave scientists with more questions than answers. By believing that more knowledge will help prevent or diagnose and treat every disease or condition that afflicts humankind, science may overestimate its reach. Yet studying these issues remains vital.
The more understanding of the basis of life and of human identity and behavior we have, the better scientists and clinicians will be able to intercede when health turns into disease and social behavior becomes problematic, according to Dr. James H. Thrall, chief of radiology at Massachusetts General Hospital, who spoke at the meeting.
"The advantage of imaging is its objectivity compared to simply clinically evaluating people with behavioral or psychiatric afflictions. The use of imaging to phenotype patients for clinical trials and for gene discovery will become extremely valuable," Thrall said.
His message was bolstered by the choice of the SNM Image of the Year, which came from a study by Nelly Alia-Klein, Ph.D., an assistant scientist, and colleagues at Brookhaven National Laboratory. Using PET with carbon-11-labeled monoamine oxidase A inhibitor clorgyline, researchers found an association between MAO-A brain activity and violent behavior. Subjects with lower MAO-A brain activity reported more aggressive behavior in a personality questionnaire and vice versa. The results indicate that an individual's genetic and brain makeup can influence aggressive behavior, even if that individual has no history of personality disorder, Alia-Klein said.
"Psychiatric illness is the number one cause of disability around the world," Thrall said. "Depression in particular steals people's ability to enjoy their lives. If we can understand the link between this multifaceted condition and what we can see on images of the brain, we will have an incredibly powerful tool."
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.